Seamount Financial Group Inc. bought a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) in the second quarter, Holdings Channel reports. The fund bought 2,993 shares of the financial services provider’s stock, valued at approximately $241,000.
A number of other hedge funds have also recently added to or reduced their stakes in MET. Kathmere Capital Management LLC raised its stake in MetLife by 88.2% during the second quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider’s stock worth $509,000 after acquiring an additional 2,965 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in MetLife by 4.8% in the first quarter. First Horizon Advisors Inc. now owns 422,684 shares of the financial services provider’s stock worth $33,937,000 after purchasing an additional 19,192 shares in the last quarter. Ritholtz Wealth Management lifted its position in shares of MetLife by 52.1% during the 1st quarter. Ritholtz Wealth Management now owns 9,355 shares of the financial services provider’s stock valued at $751,000 after acquiring an additional 3,204 shares during the period. Pinnacle Financial Partners Inc acquired a new stake in MetLife in the first quarter valued at approximately $255,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in MetLife by 20.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider’s stock worth $4,735,000 after buying an additional 10,414 shares during the last quarter. Institutional investors own 94.99% of the company’s stock.
MetLife Price Performance
Shares of NYSE MET opened at $82.34 on Tuesday. The firm has a market cap of $54.76 billion, a P/E ratio of 13.96, a PEG ratio of 0.74 and a beta of 0.86. The company has a 50 day moving average of $79.20 and a 200 day moving average of $78.14. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on MET. Keefe, Bruyette & Woods reduced their target price on shares of MetLife from $94.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, August 11th. Wolfe Research raised MetLife to a “strong-buy” rating in a report on Tuesday, September 16th. Weiss Ratings restated a “buy (b)” rating on shares of MetLife in a research report on Saturday, September 27th. Piper Sandler lowered shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price objective for the company. in a research report on Friday, September 19th. Finally, Wells Fargo & Company restated an “overweight” rating and set a $97.00 target price (up from $94.00) on shares of MetLife in a research report on Thursday, July 10th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.64.
Check Out Our Latest Stock Analysis on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Where to Find Earnings Call Transcripts
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Exceptional Stocks to Build Long-Term Wealth
- How to Use the MarketBeat Excel Dividend Calculator
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.